Funds › Alphabet Inc.
Alphabet Inc.
13F for Q3 2026, filed Nov 6, 2026. 29 positions worth $88.3B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
$88.3B−$10.7B (10.8%) vs Q2 2026Q3 2026 · filed Nov 6
Latest report
Q3 2026
filed Nov 6, 2026
Reported value
$88.3B
−$10.7B (10.8%) vs Q2 2026
Positions
29
28 in Q2 2026
Top 10 share
99.5%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Holdings, Q3 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | SPCX Space Exploration Technologies Corp. | 555.04M | $83.7B | 94.8% | +0.7% | 13F ↗ |
| 2 | CME CME Group Inc. | 3.48M | $912.7M | 1.0% | Unchanged | 13F ↗ |
| 3 | PL Planet Labs PBC | 35.25M | $577.7M | 0.7% | Unchanged | 13F ↗ |
| 4 | ARM Arm Holdings plc | 1.96M | $568.0M | 0.6% | Unchanged | 13F ↗ |
| 5 | RVMD Revolution Medicines, Inc. | 2.67M | $548.8M | 0.6% | -9.3% | 13F ↗ |
| 6 | QCOM QUALCOMM Incorporated | 2.98M | $547.9M | 0.6% | New | 13F ↗ |
| 7 | ASTS AST SpaceMobile, Inc. | 8.94M | $526.4M | 0.6% | Unchanged | 13F ↗ |
| 8 | FRSH Freshworks Inc. | 14.34M | $183.4M | 0.2% | -11.5% | 13F ↗ |
| 9 | PBLS Parabilis Medicines, Inc. | 4.92M | $158.9M | 0.2% | Unchanged | 13F ↗ |
| 10 | TEM Tempus AI, Inc. | 1.55M | $127.0M | 0.1% | Unchanged | 13F ↗ |
| 11 | PATH UiPath, Inc. | 7.03M | $90.3M | 0.1% | Unchanged | 13F ↗ |
| 12 | LIME Neutron Holdings, Inc. | 1.90M | $53.5M | 0.1% | New | 13F ↗ |
| 13 | PRME Prime Medicine, Inc. | 16.56M | $50.7M | 0.1% | Unchanged | 13F ↗ |
| 14 | PAYP PayPay Corporation · ADR | 3.13M | $49.1M | 0.1% | Unchanged | 13F ↗ |
| 15 | MAZE Maze Therapeutics, Inc. | 1.39M | $37.7M | <0.1% | Unchanged | 13F ↗ |
| 16 | FRNM Freenome, Inc. | 2.02M | $31.8M | <0.1% | New | 13F ↗ |
| 17 | RLAY Relay Therapeutics, Inc. | 1.41M | $25.5M | <0.1% | Unchanged | 13F ↗ |
| 18 | FRVO Fervo Energy Company | 1.76M | $23.9M | <0.1% | Unchanged | 13F ↗ |
| 19 | LIFE Ethos Technologies Inc. | 571,907 | $19.2M | <0.1% | -84.2% | 13F ↗ |
| 20 | OBX Obsidian Therapeutics, Inc. | 1.22M | $16.8M | <0.1% | New | 13F ↗ |
| 21 | OSCR Oscar Health, Inc. | 481,988 | $14.9M | <0.1% | Unchanged | 13F ↗ |
| 22 | BBOT BridgeBio Oncology Therapeutics, Inc. | 2.82M | $11.6M | <0.1% | Unchanged | 13F ↗ |
| 23 | SANA Sana Biotechnology, Inc. | 2.81M | $8.2M | <0.1% | Unchanged | 13F ↗ |
| 24 | BEAM Beam Therapeutics Inc. | 321,604 | $7.9M | <0.1% | Unchanged | 13F ↗ |
| 25 | VERA Vera Therapeutics, Inc. | 241,264 | $7.8M | <0.1% | Unchanged | 13F ↗ |
| 26 | FIG Figma, Inc. | 215,582 | $4.5M | <0.1% | Unchanged | 13F ↗ |
| 27 | GLUE Monte Rosa Therapeutics, Inc. | 372,474 | $4.4M | <0.1% | Unchanged | 13F ↗ |
| 28 | LYEL Lyell Immunopharma, Inc. | 293,256 | $2.9M | <0.1% | Unchanged | 13F ↗ |
| 29 | HYPR Hyperfine, Inc. | 898,720 | $728.0K | <0.1% | Unchanged | 13F ↗ |
Ten largest positions
By value, Q3 2026.
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer